tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Promising Potential of Anteris Technologies’ DurAVR System Justifies Buy Rating
PremiumRatingsPromising Potential of Anteris Technologies’ DurAVR System Justifies Buy Rating
1M ago
Anteris Technologies Reports Positive DurAVR® THV Outcomes
Premium
Company Announcements
Anteris Technologies Reports Positive DurAVR® THV Outcomes
1M ago
Anteris Technologies Presents Data from 100 DurAVR(R) THV Patients at PCR London
Premium
The Fly
Anteris Technologies Presents Data from 100 DurAVR(R) THV Patients at PCR London
1M ago
Anteris Technologies reports clinical outcomes for DurAVR THV in patients
PremiumThe FlyAnteris Technologies reports clinical outcomes for DurAVR THV in patients
2M ago
Anteris Technologies Begins Global PARADIGM Trial Enrollment
Premium
Company Announcements
Anteris Technologies Begins Global PARADIGM Trial Enrollment
2M ago
Anteris Technologies treats first patient in DurAVR heart valve pivotal trial
Premium
The Fly
Anteris Technologies treats first patient in DurAVR heart valve pivotal trial
2M ago
Anteris Technologies Gains European Clearance for Heart Valve Trial
PremiumCompany AnnouncementsAnteris Technologies Gains European Clearance for Heart Valve Trial
2M ago
Anteris receives first European regulatory clearance to commence DurAVR trial
Premium
The Fly
Anteris receives first European regulatory clearance to commence DurAVR trial
2M ago
Anteris Technologies Approves ASX Waiver Proposal
Premium
Company Announcements
Anteris Technologies Approves ASX Waiver Proposal
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100